| Drug | Interaction | Comments |
|---|---|---|
| Acetaminophen | Possible delay in onset of therapeutic effects (e.g., analgesia, antipyresis) of acetaminophen | |
| Amantadine | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Antacids | Decreased GI absorption of hyoscyamine | Administer oral hyoscyamine at least 1 hour before antacids; some manufacturers recommend administering hyoscyamine before meals and antacids after meals to prolong effects of postprandial antacid therapy, but no substantial difference in gastric pH demonstrated with such combined therapy |
| Antiarrhythmic (anticholinergic) agents | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Anticholinergic drugs | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Antidepressants, tricyclic | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Antihistamines (anticholinergic) (including meclizine) | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Antiparkinsonian (antimuscarinic) agents | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Corticosteroids | Possible increased IOP | |
| Digoxin (slow dissolving) | Possible increased serum digoxin concentration |
Use digoxin oral solution (elixir) or rapidly dissolving tablets (e.g., Lanoxin®) Observe closely for signs of digitalis toxicity |
| Glutethimide | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Haloperidol | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Ketoconazole | Increased gastric pH decreases ketoconazole absorption | Administer hyoscyamine at least 2 hours after ketoconazole |
| Levodopa | Possible increased GI metabolism of levodopa and decreased systemic concentrations | Adjust levodopa dosage if hyoscyamine is started or discontinued |
| MAO inhibitors | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Meperidine | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Muscle (anticholinergic) relaxants | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Phenothiazines | Possible additive adverse effects resulting from cholinergic blockade | Inform patient of this possibility |
| Potassium chloride | Slowed GI transit potentiates adverse GI effects of oral potassium chloride (especially wax-matrix tablets) | Caution if used concomitantly; monitor for possible GI mucosal lesions |













